Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00PZM
|
||||
| Former ID |
DNC014355
|
||||
| Drug Name |
Erythribyssin D
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530829] | ||
| Formula |
C20H20O5
|
||||
| Canonical SMILES |
CC1(C(CC2=C(O1)C=CC3=C2OC4C3COC5=C4C=CC(=C5)O)O)C
|
||||
| InChI |
1S/C20H20O5/c1-20(2)17(22)8-13-15(25-20)6-5-11-14-9-23-16-7-10(21)3-4-12(16)19(14)24-18(11)13/h3-7,14,17,19,21-22H,8-9H2,1-2H3/t14-,17?,19-/m0/s1
|
||||
| InChIKey |
ZCLUCQDBFSBCJB-OZIHFDBSSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530829] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||